invIOs Publishes Clinical Data on APN401 Cell Therapy
invIOs published clinical data on its CBL-B-silenced autologous cell therapy APN401 in a peer-reviewed journal. The announcement characterizes the data as positive.
invIOs published clinical data on its CBL-B-silenced autologous cell therapy APN401 in a peer-reviewed journal. The announcement characterizes the data as positive.